ArticleBlood2021

Repurposing a novel anti-cancer RXR agonist to attenuate murine acute GVHD and maintain graft-versus-leukemia responses.

Govindarajan Thangavelu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.